Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Luedtke

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Nature Communications|March 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig A Magaret, Li Li, Allan C deCamp, et al.
Ebiomedicine|August 24, 2025
Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320Avi Kenny, Janine van Duijn, One Dintwe, et al.
Ebiomedicine|September 5, 2024
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control studyAvi Kenny, Janine van Duijn, One Dintwe, et al.
Nature Communications|November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trialLindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical TrialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Nature Microbiology|November 10, 2022
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Iscience|November 10, 2025
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trialAlex Luedtke, Youyi Fong, Lars van der Laan, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Nature Communications|March 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig A Magaret, Li Li, Allan C deCamp, et al.
Ebiomedicine|August 24, 2025
Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320Avi Kenny, Janine van Duijn, One Dintwe, et al.
Ebiomedicine|September 5, 2024
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control studyAvi Kenny, Janine van Duijn, One Dintwe, et al.
Nature Communications|November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trialLindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical TrialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Nature Microbiology|November 10, 2022
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Iscience|November 10, 2025
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trialAlex Luedtke, Youyi Fong, Lars van der Laan, et al.
Pageof 8